Searched for
PILL PAXLOVID
Generic drug companies in no hurry to launch new Covid productsBDR Pharmaceuticals, a Mumbai-based active pharmaceutical ingredient (API) manufacturing company, has developed the API of antiviral pill P...
Drugmakers seem to be in no hurry to launch Covid antiviral pill PaxlovidSeveral industry executives and doctors ET spoke to said at the moment, while cases are rising, the need for Paxlovid hasn't been felt as c...
Rare cases of COVID returning pose questions for Pfizer pillPaxlovid has become the go-to option against COVID-19 because of its at-home convenience and impressive results in heading off severe disea...
ICMR task force meets to discuss inclusion of Pfizer’s Paxlovid for Covid treatmentPfizer’s Paxlovid contains Nirmatrelvir, which inhibits a SARS-CoV-2 protein to stop the virus from replicating, and Ritonavir, which slows...
Covid pills are here, but they aren't for everyone. Find out if you should take this medicationThe pills have to be started as soon as possible, within five days of the start of symptoms.
Optimus too could launch Covid pill Paxlovid soonThe company has conducted bioavailability and bioequivalence (BA/BE) studies and is likely to submit the safety data to the drug regulator ...
Pfizer's "game-changing" COVID-19 pill, Paxlovid, gets DCGI nodPfizer had last year announced a deal with MPP, a UN-backed body, to issue royalty-free voluntary licences to manufacture generic versions ...
World Health Organization 'strongly recommends' Pfizer's COVID-19 pillUS pharma giant Pfizer's combination of nirmatrelvir and ritonavir was the "superior choice" of treatment for unvaccinated, elderly or immu...
19 Indian companies get licence to make Pfizer's oral genericThese include Cipla, Sun Pharma, Laurus Labs, Divi's Laboratories, Glenmark, Emcure, Macleods, SMS Pharmaceuticals, Strides, Torrent, Cadil...
Cipla to conduct study on PaxlovidIn its meeting held this week, the SEC granted approval to the company to conduct bioavailability and bio equivalence (BA/BE) studies. “Cip...
China approves use of Pfizer's COVID drug PaxlovidThe National Medical Products Administration said Paxlovid is approved to treat adults who have mild to moderate COVID-19 and high risk of ...
Pfizer's COVID product sales to top $50 billion this year, investors want moreAlthough Pfizer raised its forecast for the vaccine, developed with Germany's BioNTech SE, by $1 billion to $32 billion, the drugmaker caut...
How does Merck's COVID-19 pill compare to Pfizer's?Merck in November said its full trial results showed that molnupiravir lowered the chance of hospitalization or death by about 30% in patie...
European Union's drug regulator green lights Pfizer's COVID-19 pillThe endorsement by the European Medicines Agency (EMA) allows EU member states to deploy the drug after the regulator gave guidance for its...
Britain approves Pfizer's antiviral COVID-19 pillThe approval comes as the country scrambles to build its defences amid a record hit a daily record of new COVID-19 cases on Thursday, gover...
Bangladeshi firm launches first generic of Pfizer drugBangladesh's directorate general of drug administration on Thursday granted emergency use authorisation for the oral antiviral drug to trea...
Newly infected Covid-19 patients have two new home treatment options, but there's a catchYou'll need a prescription first from a doctor or other authorized health worker.
Pill 88% effective if given early, says PfizerFinal results of Paxlovid demonstrated reduction of hospitalisation or death by 89% among high-risk patients treated within three days of s...
Pfizer says antiviral pill cut hospitalisation by 89%, neutralised Omicron in lab testsThe company said the 88% efficacy in patients treated within five days of symptom onset, was an increase from the 85% observed in the inter...
Pfizer enters deal with UN-backed MPP to license COVID drug in 95 countries including IndiaPfizer said it will waive royalties on sales in all countries covered by the agreement while COVID-19 remains classified as a Public Health...